Thanks for your replies guys. Your steady stream of updates here make for very interesting reading and have kept me optimistic for the longer term potential. Little top ups every month because I certainly have faith in the future.
It has been very frustrating at times but really feels like a tactical game at the moment with little strategic moves getting KNB set up in the right position before they go big. Or so I hope. Every RNS seems to be a positive step, another investment or partnership. All good moves.
I guess another consideration is the additional share offering. That must have watered the price down substantially as they got absorbed. But with that complete and with more positive fundamentals hopefully we get an upward trajectory soon.
Great shout about the advertising. Hadn’t really considered that. It would definitely be wasted at the moment. Hopefully there’s more interest in the MSM to positively plug the industry getting the interest building before they go big and hammer advertising. There’s lots of negatives in the world post COVID and CBD has a lot of the answers. Hopefully the NHS angle gets some real traction. I think online GP appointments are the future of the NHS and the only way they can adapt to increasing appointment requests. So it’s great that KNB has set themselves up to accommodate that already. Future proofing.
Realistically speaking and comparing to other similar companies where do we think the SP could go all things being well? I’d be super happy with £1 a share but could it go higher? £10? Imagine that.
This Canndr app is a great step forward for the promotion of cannabis based medicine, by that I mean all cannabinoid products not just THC based.
The cannabis business council is made up of the serious players in the cannabis industry ( I have attended some conferences and expos in the past) and will be the force to move things forward IMO.
Lots of potential for growth here now, on a number of fronts.
It’s gonna end the way mgc has I’m contemplating saving the £80 I have left in this product I see no future did at first, can’t see the SP moving upwards at all,
I too ducked out of MGC at a loss and I understand your trepidation about UK cannabis stocks.
I think after the hype and pandemic conditions of 2020/21, there has been an almighty and ugly crashing back down to earth. A consequence of the lack and trudge of political will and the industry perhaps looking to quickly galvanise behind a cohesive message. Im pretty certain that outside of the industry that not many people know what CBD can do. And this problem rests squarely on the shoulders of the industry.
Kanabo, unlike MGC are not diving head first into the pharma market which is a key difference. Also check the half year results in paricular operating loss, which under 9%+ inflation macro lens was an acheivement in and of itself:
● Operating loss reduced 63% to £1.4m (H1 2022: £3.72m), with strategic initiatives driving improved financial performance.
● Cash at 30 June 2023 of £4.4m (31 Dec 2022: £3.2m), to support the Group’s growth plans.
● Completed a £2.74m fundraising by way of an oversubscribed Placing in April 2023, reflecting investor confidence.
Im obviously sold on Kanabo so take my view as the choir. But Im also very much aware that there is a lot that is out of their hands. UK legislation, the damned CE mark (which gives them first to market medical grade vape pen available to the European market), and not to be ignored global instability that is Ukraine and Israel. The latter has shrunk the market’s apetitie for risk to the nth degree!
Where the UK and medical cannabis is concerned, you have to look very closley (CIC for example) but there is a very very slow march to progress. In January, cannabis will be (to a degree) legal in Germany (phase one). That might help for a short term share price boost. Otherwise, my view on Kanabo is that they are a great company in a difficult market place.
Also good news from Portugal today, but I think France is more significant. The gov., openly admitted to not knowing a jot about medical canniabis earlier this year. Seems like the conversation is beginning to flow.
I guess the CE mark could land any time, whether that is enough to set the SP on an upward trajectory without some news of market penetration.
It’s what you get with penny stocks, some you win most you don’t.
I am still counting this one a winner medium term.
I see no future did at first, can’t see the SP moving upwards at all,
